ask="2.7500"
ask_size="500"
average_daily_volume="108590"
bid="1.5300"
bid_size="500"
book_value="1.0670"
change="+0.0237"
change_from_200_day_moving_average="-0.1596"
change_from_50_day_moving_average="0.0235"
change_from_52_week_high="-4.1386"
change_From_52_week_low="0.6694"
change_in_percent="+1.4760%"
close="1.6294"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.0060"
ebitda="-16.58M"
eps_estimate_current_year="-2.9100"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-1.3700"
ex_dividend_date="N/A"
float_shares="5083000"
high="1.6700"
high_52_weeks="5.7680"
last_trade_date="3/17/2017"
last_trade_price="1.6294"
last_trade_size="100"
last_trade_time="3:58pm"
low="1.5700"
low_52_weeks="0.9600"
market_capitalization="19.05M"
moving_average_200_day="1.7890"
moving_average_50_day="1.6059"
name="PhaseRx
Inc."
notes="N/A"
one_year_target_price="10.0000"
open="1.6200"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-8.9232%"
percent_change_from_50_day_moving_average="+1.4646%"
percent_change_from_52_week_high="-71.7510%"
percent_change_from_52_week_low="+69.7292%"
previous_close="1.6057"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.5049"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11690000"
short_ratio="0.2200"
stock_exchange="NCM"
symbol="PZRX"
volume="50329"
weeks_range_52="0.9600 - 5.7680"
